Mice live longer when inflammation-boosting protein is blocked
Blocking a specific inflammation-related protein (IL-11) has been shown to extend mouse lifespans, prompting broader debate about the role of inflammation in health and aging. Commenters contrast beneficial acute inflammation, which is essential for healing and fighting infection, with harmful chronic inflammation linked to lifestyle, diet, pollutants, and autoimmune disease. They also highlight the complexity of immune signaling, limitations of mouse studies for humans, and the potential risks of broadly suppressing inflammatory pathways, even if targeted drugs or supplements look promising for longevity.
Role and Evolutionary Purpose of Inflammation
- Inflammation is described as a core part of the immune response: it helps fight infections, heal injuries, and even suppress cancer when functioning properly.
- Several comments stress that without inflammation “you’ll die,” but that too much or misdirected inflammation causes disease.
- Evolutionarily, traits are favored if they don’t kill or sterilize individuals before reproduction; strong inflammatory responses may be beneficial early in life but harmful later.
- Some speculate that current human biology is tuned for higher parasite loads and pre-modern environments.
Acute vs. Chronic Inflammation & Lifestyle
- Acute, localized inflammation from injury or infection is generally portrayed as beneficial and required for healing.
- Chronic inflammation is linked in the thread to autoimmunity, asthma, some neurodegeneration, and “first world” lifestyle factors: excess calories, high sugar/high-carb diets, stress, pollution, smoking, alcohol, sedentary behavior.
- Diets mentioned as lowering inflammation include low-carb/keto, caloric restriction, intermittent fasting, and Mediterranean-style patterns; evidence quality is acknowledged as variable.
- Exercise is said to transiently increase but then lower inflammation; blocking inflammation around exercise (e.g., NSAIDs) may blunt training adaptations.
Blocking Inflammation (IL-11 and Others) and Risks
- Many emphasize that inflammation is not a single thing; it’s a complex network of cytokines with context-dependent effects.
- Blocking a specific cytokine (like IL-11) might extend lifespan in mice, but commenters worry about impaired infection control, wound healing, and unknown long-term tradeoffs.
- Some note parallels with steroids and NSAIDs: effective at reducing inflammation, but with serious side effects (GI, bone, possibly cardiovascular).
Supplements, NAD+, and Biomarkers
- Inflammation is said to consume NAD+; this underpins interest in B3 derivatives (niacin, NMN, NR) as “anti-aging” adjuncts.
- There is debate over whether healthy, younger people benefit from NAD+-boosting supplements; some say there is “virtually no benefit” and potential downsides.
- Biomarkers like CRP and calprotectin are mentioned as practical measures of systemic inflammation.
Mouse Studies, Translation to Humans, and Skepticism
- Multiple comments caution that mouse results often fail to translate to humans; cited estimates suggest a low success rate for animal-to-human therapeutic translation.
- Artificial sweeteners and vitamin C in rodents are used as examples where rodent data misled human risk perception.
- Some argue these mouse IL-11 findings are mainly a signal for further research, not something to act on clinically or personally yet.